CNBX (CNBX Pharmaceuticals) Cyclically Adjusted Book per Share: $2.90 (As of May. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is CNBX Pharmaceuticals Cyclically Adjusted Book per Share?

CNBX Pharmaceuticals CNBX +33.33% Cyclically Adjusted Book per Share is $2.90 as of May. 2026. The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

CNBX Pharmaceuticals's adjusted book value per share for the three months ended in May. 2026 was $-0.002. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $2.90 for the trailing ten years ended in May. 2026.

During the past 12 months, CNBX Pharmaceuticals's average Cyclically Adjusted Book Growth Rate was 5.50% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 8.30% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 18.90% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was -10.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of CNBX Pharmaceuticals was 30.30% per year. The lowest was -36.20% per year. And the median was -9.80% per year.

As of today (2026-08-27), CNBX Pharmaceuticals's current stock price is $0.0002. CNBX Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in May. 2026 was $2.90. CNBX Pharmaceuticals's Cyclically Adjusted PB Ratio of today is 0.00.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of CNBX Pharmaceuticals was 62.34. The lowest was 0.01. And the median was 16.47.


CNBX Pharmaceuticals  (OTCPK:CNBX) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

CNBX Pharmaceuticals's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.0002/2.90
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of CNBX Pharmaceuticals was 62.34. The lowest was 0.01. And the median was 16.47.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


CNBX Pharmaceuticals Cyclically Adjusted Book per Share Related Terms


CNBX Pharmaceuticals Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for CNBX Pharmaceuticals's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CNBX Pharmaceuticals Cyclically Adjusted Book per Share Chart

CNBX Pharmaceuticals Annual Data
Trend Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24 Aug25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.45 2.19 3.14 3.21 2.78

CNBX Pharmaceuticals Quarterly Data
Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26 May26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.75 2.78 2.78 2.81 2.90

CNBX vs SIGY, LIPO, CARM: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, CNBX Pharmaceuticals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CNBX Pharmaceuticals Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CNBX Pharmaceuticals's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where CNBX Pharmaceuticals's Cyclically Adjusted PB Ratio falls into.



CNBX Pharmaceuticals Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, CNBX Pharmaceuticals's adjusted Book Value per Share data for the three months ended in May. 2026 was:

Adj_Book= Book Value per Share /CPI of May. 2026 (Change)*Current CPI (May. 2026)
=-0.002/335.1230*335.1230
=-0.002

Current CPI (May. 2026) = 335.1230.

CNBX Pharmaceuticals Quarterly Data

Book Value per Share CPI Adj_Book
201608 -0.523 240.849 -0.728
201611 -0.242 241.353 -0.336
201702 -0.186 243.603 -0.256
201705 2.918 244.733 3.996
201708 2.951 245.519 4.028
201711 2.432 246.669 3.304
201802 3.235 248.991 4.354
201805 2.618 251.588 3.487
201808 2.612 252.146 3.472
201811 8.254 252.038 10.975
201902 16.305 252.776 21.617
201905 17.248 256.092 22.571
201908 13.153 256.558 17.181
201911 5.376 257.208 7.005
202002 2.801 258.678 3.629
202005 4.528 256.394 5.918
202008 1.567 259.918 2.020
202011 1.114 260.229 1.435
202102 3.357 263.014 4.277
202105 1.963 269.195 2.444
202108 1.458 273.567 1.786
202111 0.506 277.948 0.610
202202 -0.520 283.716 -0.614
202205 -0.954 292.296 -1.094
202208 -1.297 296.171 -1.468
202211 -1.569 297.711 -1.766
202302 -0.911 300.840 -1.015
202305 -0.119 304.127 -0.131
202308 -0.089 307.026 -0.097
202311 -0.074 307.051 -0.081
202402 -0.076 310.326 -0.082
202405 -0.079 314.069 -0.084
202408 -0.080 314.796 -0.085
202411 -0.081 315.493 -0.086
202502 -0.076 319.082 -0.080
202505 -0.027 321.465 -0.028
202508 -0.005 323.976 -0.005
202511 -0.003 324.122 -0.003
202602 -0.002 326.785 -0.002
202605 -0.002 335.123 -0.002

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $2.90 mean?
CNBX Pharmaceuticals (CNBX) has a Cyclically Adjusted Book per Share of $2.90 as of May. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on CNBX Pharmaceuticals and its competitors.
Is CNBX Pharmaceuticals' Cyclically Adjusted Book per Share too high?
CNBX Pharmaceuticals' current Cyclically Adjusted Book per Share is $2.90.
How does CNBX Pharmaceuticals' Cyclically Adjusted Book per Share compare to SIGY and LIPO?
CNBX Pharmaceuticals' Cyclically Adjusted Book per Share of $2.90 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on CNBX Pharmaceuticals and its competitors. CNBX Pharmaceuticals's current Cyclically Adjusted Book per Share is $2.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CNBX Pharmaceuticals stock overvalued right now?
CNBX Pharmaceuticals (CNBX) has a current Cyclically Adjusted Book per Share of $2.90. The current Cyclically Adjusted Book per Share is $2.90. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For CNBX Pharmaceuticals (CNBX), the current Cyclically Adjusted Book per Share is $2.90 as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CNBX Pharmaceuticals Business Description

Address No. 3 Bethesda Metro Center, Suite 700, Bethesda, MD, USA, 20814
CNBX Pharmaceuticals Inc is a clinical-stage biotechnology company. It develops pharmaceuticals focusing on cancer research utilizing HTS technology and personalized bioinformatics tools. The company's main focus is the development of cannabinoid therapies and other technologies for the treatment of cancer, mainly cancers of the gastrointestinal tract, skin, breast, and prostate. The firm's main product is the Cannabics SR, an oral capsule developed for the treatment of patients with cancer and cancer anorexia cachexia syndrome (CACS). It also has an anti-neoplastic drug candidate under development for Colorectal Cancer (CRC) named RCC-33.